Abstract
Background: One of the more vigorous debates in the field of highly active antiretroviral therapy (HAART) is how to start it and what the optimal drug sequence is. Methods: A retrospective cohort analysis was performed. The aim was to evaluate which variables could influence the virological response to second-line genotypic-based HAART in patients with virological documented first-line HAART failure. A positive response was defined as a confirmed HIV RNA level
| Original language | English |
|---|---|
| Pages (from-to) | 923-929 |
| Number of pages | 7 |
| Journal | Antiviral Therapy |
| Volume | 11 |
| Issue number | 7 |
| Publication status | Published - 2006 |
Fingerprint
ASJC Scopus subject areas
- Pharmacology
Cite this
The effect of HIV-1 resistance mutations after first-line virological failure on the possibility to sequence antiretroviral drugs in second-line regimens. / Maggiolo, Franco; Ripamonti, Diego; Torti, Carlo; Arici, Claudio; Antinori, Andrea; Quiros-Roldan, Eugenia; Minoli, Lorenzo; Sighinolfi, Laura; Nasta, Paola; Suter, Fredy.
In: Antiviral Therapy, Vol. 11, No. 7, 2006, p. 923-929.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - The effect of HIV-1 resistance mutations after first-line virological failure on the possibility to sequence antiretroviral drugs in second-line regimens
AU - Maggiolo, Franco
AU - Ripamonti, Diego
AU - Torti, Carlo
AU - Arici, Claudio
AU - Antinori, Andrea
AU - Quiros-Roldan, Eugenia
AU - Minoli, Lorenzo
AU - Sighinolfi, Laura
AU - Nasta, Paola
AU - Suter, Fredy
PY - 2006
Y1 - 2006
N2 - Background: One of the more vigorous debates in the field of highly active antiretroviral therapy (HAART) is how to start it and what the optimal drug sequence is. Methods: A retrospective cohort analysis was performed. The aim was to evaluate which variables could influence the virological response to second-line genotypic-based HAART in patients with virological documented first-line HAART failure. A positive response was defined as a confirmed HIV RNA level
AB - Background: One of the more vigorous debates in the field of highly active antiretroviral therapy (HAART) is how to start it and what the optimal drug sequence is. Methods: A retrospective cohort analysis was performed. The aim was to evaluate which variables could influence the virological response to second-line genotypic-based HAART in patients with virological documented first-line HAART failure. A positive response was defined as a confirmed HIV RNA level
UR - http://www.scopus.com/inward/record.url?scp=33750954314&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33750954314&partnerID=8YFLogxK
M3 - Article
C2 - 17302255
AN - SCOPUS:33750954314
VL - 11
SP - 923
EP - 929
JO - Antiviral Therapy
JF - Antiviral Therapy
SN - 1359-6535
IS - 7
ER -